Advanced search
Publication Cover
Patient Preference and Adherence Volume 15, 2021 - Issue
Submit an article Journal homepage
105
Views
3
CrossRef citations to date
0
Altmetric
Short Report

Concordance Between Persons with Multiple Sclerosis and Treating Physician on Medication Effects and Health Status

Efrat Neter1 Department of Behavioral Sciences, Ruppin Academic Center, Emeq Hefer, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2162-0474View further author information
ORCID Icon,
Lea Glass-Marmor2 Multiple Sclerosis Center & Department of Neurology, Carmel Medical Center, Haifa, IsraelView further author information
,
Loren Haiien2 Multiple Sclerosis Center & Department of Neurology, Carmel Medical Center, Haifa, IsraelView further author information
&
Ariel Miller2 Multiple Sclerosis Center & Department of Neurology, Carmel Medical Center, Haifa, Israel;3 Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, IsraelView further author information
Pages 939-943 | Published online: 07 May 2021

References

  • Yeandle D, Rieckmann P, Giovannoni G, Alexandri N, Langdon D. Patient power revolution in multiple sclerosis: navigating the new frontier. Neurol Ther. 2018;7(2):179–187. doi:10.1007/s40120-018-0118-8
  • Kasper J, Köpke S, Mühlhauser I, Nübling M, Heesen C. Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial. Eur J Neurol. 2008;15(12):1345–1352. doi:10.1111/j.1468-1331.2008.02313.x
  • Colligan E, Metzler A, Tiryaki E. Shared decision-making in multiple sclerosis. Mult Scler. 2017;23(2):185–190. doi:10.1177/1352458516671204
  • Poulos C, Wakeford C, Kinter E, Mange B, Schenk T. Patient and physician preferences for multiple sclerosis treatments in Germany: a discrete-choice experiment study. Mult Scler J Exp Transl Clin. 2020;6(1):1–14. doi:10.1177/2055217320910778
  • Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Prim. 2018;4(1):1–27. doi:10.1038/s41572-018-0041-4
  • Teter B, Agashivala N, Kavak K, Chouhfeh L, Hashmonay R, Weinstock-Guttman B. Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis. Mult Scler J. 2014;20(7):830–836. doi:10.1177/1352458513513058
  • Koudriavtseva T, Onesti E, Pestalozza IF, Sperduti I, Jandolo B. The importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disability. Neurol Sci. 2012;33(3):575–584. doi:10.1007/s10072-011-0776-0
  • Kremenchutzky M, Walt L. Perceptions of health status in multiple sclerosis patients and their doctors. Can J Neurol Sci. 2013;40(2):210–218. doi:10.1017/S0317167100013755
  • Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. Br Med J. 1997;314:1580–1583. doi:10.1136/bmj.314.7094.1580
  • Heesen C, Kleiter I, Nguyen F, Schaffler N, Kasper J, Kopke S. Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Mult Scler. 2010;16(12):1507–1512. doi:10.1177/1352458510379819
  • Zettl UK, Bauer-Steinhusen U, Glaser T, Hechenbichler K, Hecker M. Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy. BMC Neurol. 2016;16(1):181. doi:10.1186/s12883-016-0705-1
  • Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2(1):12. doi:10.1186/1477-7525-2-12
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded\ndisability status scale (EDSS). Neurology. 1983;33(11):1444–1452. doi:10.1212/WNL.33.11.1444
  • Kantor D, Bright JR, Burtchell J. Perspectives from the patient and the healthcare professional in multiple sclerosis: social media and patient education. Neurol Ther. 2018. doi:10.1007/s40120-017-0087-3
  • Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Treatment satisfaction in multiple sclerosis. Int J MS Care. 2014;16(2):68–75. doi:10.7224/1537-2073.2013-021
  • Haase R, Kullmann JS, Ziemssen T. Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey. Ther Adv Neurol Disord. 2016;9(4):250–263. doi:10.1177/1756285616634247
  • Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008;26(8):661–677. doi:10.2165/00019053-200826080-00004
  • Lejbkowicz I, Caspi O, Miller A. Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis. Expert Rev Neurother. 2012;12(3):343–352. doi:10.1586/ern.11.161

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.